Valiant Organics Limited has informed the Exchange regarding Outcome of Board Meeting held on May 19, 2026, wherein the proposal w.r.t. cessation of a Company as a Partner from Subsidiary, proposed material RPT with Subsidiary and etc. has been approved.
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Valiant Organics Limited's Board has approved the cessation of its partnership interest in Dhanvallabh Ventures LLP (DVLLP). Upon completion, DVLLP will cease to be a subsidiary of the company. As settlement, Valiant Organics will receive 1,86,07,531 equity shares of Valiant Laboratories Limited, determined at fair market value on an arm's length basis. The transaction requires shareholder approval via special resolution under SEBI Listing Regulations and Section 188 of Companies Act. DVLLP contributed 0.3756 Crores (0.05%) to consolidated turnover and 83.79 Crores (11.34%) to net worth for FY2026. The transaction is supported by a valuation report from GBCA & Associates LLP.
The divestment simplifies Valiant Organics' corporate structure by removing a subsidiary layer. Shareholders gain exposure to listed equity shares of Valiant Laboratories Limited instead of an unlisted partnership interest, which could improve liquidity and transparency of underlying assets.